Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015, 159(3):341-346 | DOI: 10.5507/bp.2014.032

MDR1 gene polymorphisms and P-glycoprotein expression in respiratory diseases

Maja Milojkovica, Nena Milacicb, Jelena Radovica, Srdjan Ljubisavljevica
a Institute of Pathophysiology, Medical Faculty, University of Nis, Serbia
b Clinic of Internal Medicine, Department of Pulmology, Clinical Center of Montenegro, Podgorica, Montenegro

Background: P-glycoprotein (P-gp/MDR1), a member of the ATP-binding cassette (ABC) transporters super family, encoded by the ABCB1/MDR1 gene, is one of suggested respiratory tract protection components, found in various tissues with a barrier function, such as tracheobronchial epithelium and lung parenchyma. As an ATP-dependent pump, P-gp extrudes lipophilic particles out of cells and acts as a gatekeeper against numerous xenobiotics, with a protective role in mediating DNA damage, secretion of toxic compounds, apoptosis and the immune response. Therefore, a presence of MDR1 polymorphisms and altered P-gp expression may be important for pathogenesis of reduced lung inflammatory response on cigarette smoke exposure, as well as for the severity of chronic obstructive pulmonary disease and lung cancer pathogenesis and treatment efficacy.

Methods and Results: We have analyzed data available from experimental and clinical studies performed to establish the role of MDR1 polymorphisms, especially the 3435C>T variation, and P-gp expression in pathogenesis and clinical outcome of human respiratory diseases.

Conclusions: Although there are indications that altered expression of P-gp and/or polymorphisms of MDR1 gene play an important role in respiratory diseases pathogenesis and treatment, their exact role and relevance are insufficiently investigated, with exception of certain chemotherapeutic agents' efficacy in lung cancer treatment. Further research in this field, including bigger series of patients, is necessary for better understanding of respiratory diseases' pathogenesis and treatment.

Keywords: P-gp expression, MDR1 polymorphisms, respiratory diseases, COPD, lung cancer

Received: November 25, 2013; Accepted: June 4, 2014; Prepublished online: June 23, 2014; Published: September 30, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Milojkovic, M., Milacic, N., Radovic, J., & Ljubisavljevic, S. (2015). MDR1 gene polymorphisms and P-glycoprotein expression in respiratory diseases. Biomedical papers159(3), 341-346. doi: 10.5507/bp.2014.032
Download citation

References

  1. Dean M, Hamon Y, Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 2001;42:1007-17. Go to original source...
  2. Scheffer GL, Pijnenborg AC, Smit EF, Muller M, Postma DS, Timens W, van der Valk P, de Vries EG, Scheper RJ. Multidrug resistance related molecules in human and murine lung. J Clin Pathol 2002;55:332-9. Go to original source... Go to PubMed...
  3. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000;97:3473-8. Go to original source... Go to PubMed...
  4. Cascorbi I, Gerloff T, Johne A, Meisel C, Hoffmeyer S, Schwab M, Schaeffeler E, Eichelbaum M, Brinkmann U, Roots I. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther 2001;69:169-74. Go to original source... Go to PubMed...
  5. Kroetz DL, Pauli-Magnus C, Hodges LM, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE, DeYoung J, Taylor T, Carlson EJ, Herskowitz I, Giacomini KM, Clark AG. Pharmacogenetics of Membrane Transporters Investigators: Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene. Pharmacogenetics 2003;13:481-94. Go to original source... Go to PubMed...
  6. Tang K, Wong LP, Lee EJ, Chong SS, Lee CG. Genomic evidence for recent positive selection at the human MDR1 gene locus. Hum Mol Genet 2004;13:783-97. Go to original source... Go to PubMed...
  7. Milojkovic M, Stojnev S, Jovanovic I, Ljubisavljevic S, Stefanovic V, Sunder-Plassman R. Frequency of the C1236T, G2677T/A and C3435T MDR1 gene polymorphisms in the Serbian population. Pharmacol Rep 2011;63:808-14. Go to original source... Go to PubMed...
  8. Fung KL, Gottesman MM. A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. Biochimica Biophysica Acta 2009;1794:860-71. Go to original source...
  9. Ieri I. Functional significance of genetic polymorphisms in P-glycoprotein (MDR1, ABCB1) and breast cancer resistance protein (BCRP, ABCG2). Drug Metab Pharmacokinet 2012;27:85-105. Go to original source... Go to PubMed...
  10. Schinkel AH, Wagenaar E, Mol CA, van Deemter L. P-glycoprotein in blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest 1996;97:2517-24. Go to original source... Go to PubMed...
  11. Yamagishi T, Sahni S, Sharp DM, Arvind A, Jansson PJ, Richardson DR. P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration. J Biol Chem 2013;288:31761-71. Go to original source... Go to PubMed...
  12. Schwab M, Eichelbaum M, Fromm MF. Genetic polymorphisms of the human MDR1 drug transporter. Annu Rev Pharmacol Toxicol 2003;43:285-307. Go to original source... Go to PubMed...
  13. Kurata Y, Ieiri I, Kimura M, Morita T, Irie S, Urae A, Ohdo S, Ohtani H, Sawada Y, Higuchi S and Otsubo K. Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein. Clin Pharmacol Ther 2002;72:209-19. Go to original source... Go to PubMed...
  14. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U. Functional polymorphisms of the human multidrugresistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000;97:3473-8. Go to original source... Go to PubMed...
  15. Bazrafshani MR, Poulton KV, Mahmoodi M. A linkage and association analysis study in the multidrug resistance gene 1 (MDR1) in renal patients. Int J Mol Epidemiol Genet 2012;3:314-20. Go to PubMed...
  16. Langmann T, Mauerer R, Zahn A, Moehle C, Probst M, Stremmel W, Schmitz G: Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues. Clin Chem 2003;49:230-8. Go to original source... Go to PubMed...
  17. Scheffer GL, Pijnenborg AC, Smit EF, Muller M, Postma DS, Timens W, van der Valk P, de Vries EG, Scheper RJ. Multidrug resistance related molecules in human and murine lung. J Clin Pathol 2002;55:332-9. Go to original source... Go to PubMed...
  18. Lechapt-Zalcman E, Hurbain I, Lacave R, Commo F, Urban T, Antoine M, Milleron B, Bernaudin JF. MDR1-Pgp 170 expression in human bronchus. Eur Respir J 1997;10:1837-43. Go to original source... Go to PubMed...
  19. Wioland MA, Fleury-Feith J, Corlieu P, Commo F, Monceaux G, Lacau-St-Guily J, Bernaudin JF. CFTR, MDR1, and MRP1 immunolocalization in normal human nasal respiratory mucosa. J Histochem Cytochem 2000;48:1215-22. Go to original source... Go to PubMed...
  20. Campbell L, Abulrob AN, Kandalaft LE, Plummer S, Hollins AJ, Gibbs A, Gumbleton M. Constitutive expression of p-glycoprotein in normal lung alveolar epithelium and functionality in primary alveolar epithelial cultures. J Pharmacol Exp Ther 2003;304:441-52. Go to original source... Go to PubMed...
  21. Cordon-Cardo C, O'Brien JP, Boccia J, Casals D, Bertino JR, Melamed MR. Expression of the multidrug resistance gene product (P glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 1990;38:1277-87. Go to original source... Go to PubMed...
  22. Scomma H, Lechevalier E, Lacarelle B, Barra Y. Modulation of MDR1 and CYP3A expression by dexamethasone: evidence for an inverse regulation in adrenals. Biochem Biophys Res Commun 1998;252:392-5. Go to original source... Go to PubMed...
  23. Schinkel AH, Mayer U, Wagenaar E, Mol CA, van Deemter L, Smit JJ, van der Valk MA, Voordouw AC, Spits H, van Tellingen O, Zijlmans JM, Fibbe WE, Borst P. Normal viability and altered pharmacokinetics in mice lacking MDR1-type (drug-transporting) Pglycoproteins. Proc Natl Acad Sci USA 1997;94:4028-33. Go to original source... Go to PubMed...
  24. Van der Deen M, Timens W, Timmer-Bosscha H, van der Strate BW, Scheper RJ, Postma DS, de Vries EG, Kerstjens HA. Reduced inflammatory response in cigarette smoke exposed Mrp1/Mdr1a/1b deficient mice. Respir Res 2007;8:49. Go to original source... Go to PubMed...
  25. Brady JM, Cherrington NJ, Hartley DP, Buist SC, Li N, Klaassen CD. Tissue distribution and chemical induction of multiple drug resistance genes in rats. Drug Metab Dispos 2002;30:838-44. Go to original source... Go to PubMed...
  26. Hendrikse NH, de Vries EG, Eriks-Fluks L, van der Graaf WT, Hospers GA, Willemsen AT, Vaalburg W, Franssen EJ. A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier. Cancer Res 1999;59:2411-6.
  27. Roerig DL, Audi SH, Ahlf SB. Kinetic characterization of p-glycoprotein-mediated efflux of rhodamine 6g in the intact rabbit lung. Drug Metab Dispos 2004;32:953-8. Go to original source... Go to PubMed...
  28. Forbes II. Human airway epithelial cell lines for in vitro drug transport and metabolism studies. Pharm Sci Technol Today 2000;3:18-27. Go to original source... Go to PubMed...
  29. Ehrhardt C, Kneuer C, Laue M, Schaefer UF, Kim KJ, Lehr CM. 16HBE14o- human bronchial epithelial cell layers express P-glycoprotein, lung resistance-related protein, and caveolin-I. Pharm Res 2003;20:545-51. Go to original source... Go to PubMed...
  30. Hamilton KO, Yazdanian MA, Audus KL. Modulation of P-glycoprotein activity in Calu-3 cells using steroids and beta-ligands. Int J Pharm 2001;228:171-9. Go to original source... Go to PubMed...
  31. Hamilton KO, Topp E, Makagiansar I, Siahaan T, Yazdanian M, Audus KL. Multidrug resistance-associated protein-1 functional activity in Calu-3 cells. J Pharmacol Exp Ther 2001;298:1199-205. Go to PubMed...
  32. Lehmann T, Kohler C, Weidauer E, Taege C, Foth H. Expression of MRP1 and related transporters in human lung cells in culture. Toxicology 2001;167:59-72. Go to original source... Go to PubMed...
  33. Rüstemoglu A, Gumus-Akay G, Yigit S, Tasliyurt T. Analysis of common MDR1 (ABCB1) gene C1236T and C3435T polymorphisms in Turkish patients with Familial Mediterranean Fever. Genet Mol Res 2011;14:3411-20. Go to original source... Go to PubMed...
  34. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-73. Go to original source... Go to PubMed...
  35. Dogan OT, Katrancioglu N, Karahan O, Sanli GC, Zorlu A, Manduz S. Frequency of the MDR-1 C>T gene polymorphism in patients with COPD. Clinics (Sao Paulo) 2010;65:1115-7. Go to PubMed...
  36. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2013). GOLD. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf. 
  37. Izzotti A, Cartiglia C, Longobardi M, Balansky RM, D'agostino F, Lubet RA, De Flora S. Alterations of gene expression in skin and lung of mice exposed to light and cigarette smoke. FASEB J 2004;18:1559-61. Go to original source... Go to PubMed...
  38. Papp E, Gadawski I, Cote HC. Longitudinal effects of thymidine analogues on mtDNA, mtRNA and multidrug resistance (MDR-1) induction in cultured cells. J Antimicrob Chemother 2008;61:1048-52. Go to original source... Go to PubMed...
  39. Israeli D, Ziaei S, Gonin P, Garcia L. A proposal for the physiological significance of mdr1 and Bcrp1/Abcg2 gene expression in normal tissue regeneration and after cancer therapy. J Theor Biol 2005;232:41-5. Go to original source... Go to PubMed...
  40. Van der Deen M, Marks H, Willemse BW, Postma DS, Mueller M, Smit EF, Scheffer GL, Scheper RJ, de Vries EG, Timens W. Diminished expression of multidrug resistance-associated protein 1 (MRP1) in bronchial epithelium of COPD patients. Virchows Arch 2006;449:682-8. Go to original source... Go to PubMed...
  41. Piquette-Miller M, Pak A, Shahzamani A. Decreased Expression and Activity of P-Glycoprotein in Rat Liver During Acute Inflamation. Pharmaceut Res 1998;15:706-11. Go to original source... Go to PubMed...
  42. Fardel O, Lecureur V, Guillouzo A. The P-glycoprotein multidrug transporter. Gen Pharmacol 1996;27:1283-91 Go to original source... Go to PubMed...
  43. Beer TW, Rowlands DC, Crocker J. Detection of the multidrug resistance marker P-glycoprotein by immunohistochemistry in malignant lung tumours. Thorax 1996;51:526-9. Go to original source... Go to PubMed...
  44. Sinues B, Fanlo A, Bernal ML, Mayayo E, Bello S, Rubio E, Isla D. MDR-1 C3435T genetic polymorphism and tobacco-related lung cancer. Oncology 2003;64:183-5. Go to original source... Go to PubMed...
  45. Eichelaum M, Fromm MF, Schwab M. Clinical aspects of the MDR1 (ABCB1) gene polymorphism. Ther Drug Monit 2004;26:180-5 Go to original source... Go to PubMed...
  46. Sohn JW, Lee SY, Lee SJ, Kim EJ, Cha SI, Kim CH, Lee JT, Jung TH, Park JY. MDR1 polymorphisms predict the response to etoposide-cisplatin combination chemotherapy in small cell lung cancer. Jpn J Clin Oncol 2006;36:137-41. Go to original source... Go to PubMed...
  47. Pan JH, Han JX, Wu JM, Huang HN, Yu QZ, Sheng LJ. MDR1 single nucleotide polymorphism G2677T/A and haplotype are correlated with response to docetaxel-cisplatin chemotherapy in patients with non-small-cell lung cancer. Respiration 2009;78:49-55. Go to original source... Go to PubMed...
  48. Isla D, Sarries C, Rosell R, Alonso G, Domine M, Taron M, Lopez-Vivanco G, Camps C, Botia M, Nunez L, Sanchez-Ronco M, Sanchez JJ, Lopez-Brea M, Barneto I, Paredes A, Medina B, Artal A, Lianes P. Single nucleotide polymorphisms and outcome in docetaxel-cisplatin- treated advanced non-small-cell lung cancer. Ann Oncol 2004;15:1194-203. Go to original source... Go to PubMed...
  49. Volm M, Mattern J, Samsel B. Relationship of inherent resistance to doxorubicin, proliferative activity and expression of Pglycoprotein 170, and glutathione S-transferase-pi in human lung tumors. Cancer 1992;70:764-9. Go to original source... Go to PubMed...
  50. Volm M, Mattern J, Samsel B. Overexpression of P-glycoprotein and glutathione S-transferase-pi in resistant non-small cell lung carcinomas of smokers. Br J Cancer 1991;64:700-4. Go to original source... Go to PubMed...
  51. Wood L, Palmer M, Hewitt J, Urtasun R, Bruera E, Rapp E, Thaell JF. Results of a phase III, double-blind, placebo-controlled trial of megestrol acetate modulation of P-glycoprotein-mediated drug resistance in the first-line management of smallcell lung carcinoma. Br J Cancer 1998;77:627-31. Go to original source... Go to PubMed...
  52. Zheng H, Zeevi A, Schuetz E, Lamba J, McCurry K, Griffith BP, Webber S, Ristich J, Dauber J, Iacono A, Grgurich W, Zaldonis D, McDade K, Zhang J, Burckart GJ. Tacrolimus dosing in adult lung transplant patients is related to cytochrome P4503A5 gene polymorphism. J Clin Pharmacol 2004;44:135-40. Go to original source... Go to PubMed...
  53. Trussardi-Regnier A, Millot JM, Gorisse MC, Delvincourt C, Prevost A. Detection of drug-resistance genes using single bronchoscopy biopsy specimens. Oncol Rep 2007;18:703-8. Go to original source... Go to PubMed...